scispace - formally typeset
R

Romain Colle

Researcher at Université Paris-Saclay

Publications -  78
Citations -  1374

Romain Colle is an academic researcher from Université Paris-Saclay. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 15, co-authored 50 publications receiving 737 citations. Previous affiliations of Romain Colle include French Institute of Health and Medical Research & University of Paris-Sud.

Papers
More filters
Journal ArticleDOI

Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.

TL;DR: In a prospective uncontrolled cohort study, survivors of COVID-19 who had been hospitalized in a university hospital in France between March 1 and May 29, 2020, underwent a telephone assessment 4 months after discharge, between July 15 and September 18, 2020 as mentioned in this paper.
Journal ArticleDOI

The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age.

TL;DR: This study provides an essential baseline for defining the “normal” metabolome and its main sources of variation in healthy volunteers and established reference human metabolome values in a large and well-defined population of French healthy volunteers.
Journal ArticleDOI

Post-acute COVID-19 syndrome

TL;DR: The presentation, prevalence, pathophysiology and evolution of respiratory complications and other organ-related injuries associated with post-acute COVID-19 syndrome will be a major issue for various healthcare providers in the coming months.
Journal ArticleDOI

Depressed suicide attempters have smaller hippocampus than depressed patients without suicide attempts

TL;DR: Depressed suicide attempters have smaller hippocampus than depressed patients without suicide attempts, independently from socio-demographic, MDD and MDE characteristics, suggesting that hippocampal volume could be a suicidal state marker in MDE.
Journal ArticleDOI

PPAR-γ Agonists for the Treatment of Major Depression: A Review.

TL;DR: PPAR-γ agonists may have antidepressant properties, which need to be assessed in further studies of major depressive episodes, and are associated with changes in biomarkers of metabolism and inflammation.